Furthermore, we enrolled 200 newly diagnosed PCa patients in our centers and investigated the serum expression of MTR by ELISA and utilized in-silico tools to confirm the results of our meta-analysis. The gene discussed is MTR; the disease is posterior cortical atrophy.